Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Looking for quick cash jobs near you? Discover local opportunities that can help you earn money fast.
25,479 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Ballard Power is at a pivotal moment as 2025 unfolds. This guide breaks down what to watch in the Q4 transcript, how ...
A high-profile Texas ruling removed Roc Nation from a cluster of lawsuits linked to a celebrity legal fight. This art...
A veteran portfolio manager recounts selling a 19-bagger too early and explains how that misstep reshaped his long-te...
A high-profile insider sale at Mineralys raises questions about what it might mean for the biotech's near-term trajec...
Upstart’s growth engine faces higher costs that squeeze margins, triggering a drop in price even when revenue beats. ...
Bitcoin is testing new support near $60,000 as Strategy Shares hover below the $100 mark. This dual move highlights h...
Snowflake stock down hard has sparked headlines and worries about growth. But the core platform—cross‑cloud data ware...
OpenAI’s fresh developments could tilt the landscape for AI hardware suppliers. This guide explains what Broadcom sto...
In April, nebius group stock popped as investors weighed cloud and AI catalysts. This piece breaks down the drivers, ...
The race to dominate AI computing hinges on four key players. This article breaks down who stands to win, what the nu...
Nvidia sits at the center of the AI boom, but the stock story is complex. This guide explains what's driving Nvidia, ...